Allogene Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +0.4% | -99.4% | -60.9% | -76.8% | -100.0% | |
| – | – | +235.1% | +129.6% | +13.2% | +28.0% | -15.1% | -3.9% | -9.4% | |
| – | – | – | – | – | -99.4% | -60.9% | -76.8% | -56,277.3% | |
| – | +0.0% | -4.8% | +33.5% | +14.1% | +16.4% | -5.3% | -20.8% | -21.9% | |
| – | +170,658.3% | +40.2% | +13.5% | +13.6% | +7.0% | -9.6% | -9.0% | -12.9% | |
| – | +9,642,000.0% | +4.8% | +27.8% | +14.0% | +14.1% | -2.3% | -16.7% | -28.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +49.7% | +82.3% | +14.1% | +63.7% | +0.0% | -98.9% | +493.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | -939,936.4% | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.